Authors:
Dube, MP
Edmondson-Melancon, H
Qian, D
Aqeel, R
Johnson, D
Buchanan, TA
Citation: Mp. Dube et al., Prospective evaluation of the effect of initiating indinavir-based therapyon insulin sensitivity and B-cell function in HIV-infected patients, J ACQ IMM D, 27(2), 2001, pp. 130-134
Authors:
Runnebaum, IB
Wang-Gohrke, S
Vesprini, D
Kreienberg, R
Lynch, H
Moslehi, R
Ghadirian, P
Weber, B
Godwin, AK
Risch, H
Garber, J
Lerman, C
Olopade, OI
Foulkes, WD
Karlan, B
Warner, E
Rosen, B
Rebbeck, T
Tonin, P
Dube, MP
Kieback, DG
Narod, SA
Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638
Authors:
Kemper, CA
Witt, MD
Keiser, PH
Dube, MP
Forthal, DN
Leibowitz, M
Smith, DS
Rigby, A
Hellmann, NS
Lie, YS
Leedom, J
Richman, D
McCutchan, JA
Haubrich, R
Citation: Ca. Kemper et al., Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors, AIDS, 15(5), 2001, pp. 609-615
Citation: Mp. Dube et A. Olivier, Striga gesnerioides an its hosts, the cowpea: Interaction and methods of control, CAN J BOTAN, 79(10), 2001, pp. 1225-1240
Authors:
Dube, MP
Sprecher, D
Henry, WK
Aberg, JA
Torriani, FJ
Hodis, HN
Schouten, J
Levin, J
Myers, G
Zackin, R
Nevin, T
Currier, JS
Citation: Mp. Dube et al., Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group, CLIN INF D, 31(5), 2000, pp. 1216-1224
Authors:
Kibar, Z
Dube, MP
Powell, J
McCuaig, C
Hayflick, SJ
Zonana, J
Hovnanian, A
Radhakrishna, U
Antonarakis, SE
Benohanian, A
Sheeran, AD
Stephan, ML
Gosselin, R
Kelsell, DP
Christianson, AL
Fraser, FC
Kaloustian, VMD
Rouleau, GA
Citation: Z. Kibar et al., Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping, EUR J HUM G, 8(5), 2000, pp. 372-380
Authors:
Haubrich, RH
Little, SJ
Currier, JS
Forthal, DN
Kemper, CA
Beall, GN
Johnson, D
Dube, MP
Hwang, JY
McCutchan, JA
Citation: Rh. Haubrich et al., The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response, AIDS, 13(9), 1999, pp. 1099-1107
Authors:
Dunne, MW
Bozzette, S
McCutchan, JA
Dube, MP
Sattler, FR
Forthal, D
Kemper, CA
Havlir, D
Citation: Mw. Dunne et al., Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial, LANCET, 354(9182), 1999, pp. 891-895
Citation: Rt. Koda et al., Pharmacokinetics of trimetrexate and dapsone in AIDS patients with Pneumocystis carinii pneumonia, J CLIN PHAR, 39(3), 1999, pp. 268-274
Authors:
Sattler, FR
Jaque, SV
Schroeder, ET
Olson, C
Dube, MP
Martinez, C
Briggs, W
Horton, R
Azen, S
Citation: Fr. Sattler et al., Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus, J CLIN END, 84(4), 1999, pp. 1268-1276
Authors:
Havlir, DV
Dube, MP
McCutchan, JA
Forthal, DN
Kemper, CA
Dunne, MW
Parenti, DM
Kumar, PN
White, AC
Witt, MD
Nightingale, SD
Sepkowitz, KA
MacGregor, RR
Cheeseman, SH
Citation: Dv. Havlir et al., Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS, CLIN INF D, 27(6), 1998, pp. 1369-1375